Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-30

Clinical Trial Update: Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Vinorelbine/Carboplatin versus Gemcitabine/Carboplatin in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine/Carboplatin
  • Vinorelbine/Carboplatin

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN